Research progress of the Otubains subfamily in hepatocellular carcinoma

Yanming Wu1, Sa'udah Badriah Mohd Sani1, Ke Peng2

  • 1Department of Biomedical Sciences, Advanced Medical and Dental Institute, Universiti Sains Malaysia, Bertam, Kepala Batas, Penang 13200, Malaysia.

Insights

The Otubain Subfamily, including OTUB1 and OTUB2, plays a role in cancer development. Understanding these deubiquitinating enzymes could lead to new treatments for hepatocellular carcinoma (HCC).

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Ubiquitination is a key post-translational modification regulating protein function in physiological processes.
  • The Otubain Subfamily, comprising OTUB1 and OTUB2, are deubiquitinating enzymes implicated in cancer development.
  • Hepatocellular carcinoma (HCC) is a prevalent cancer globally, with significant expression of OTUB1 and OTUB2 observed in HCC cells.

Purpose of the Study:

  • To investigate the role of the Otubain Subfamily (OTUB1 and OTUB2) in tumorigenesis, specifically in hepatocellular carcinoma (HCC).
  • To highlight the potential of OTUB1 and OTUB2 as molecular targets for advancing HCC treatments.

Main Methods:

  • Review of existing literature on deubiquitination pathways, oncogenesis, and the expression/function of OTUB1 and OTUB2 in cancer.
  • Analysis of studies linking OTUB1 and OTUB2 expression to HCC incidence and development.

Main Results:

  • OTUB1 and OTUB2 are significantly expressed in HCC cells.
  • OTUB1 demonstrates important biological functions in cancer, suggesting a role in tumorigenesis.
  • The precise mechanisms of OTUB1 and OTUB2 in liver cancer require further elucidation.

Conclusions:

  • The Otubain Subfamily (OTUB1 and OTUB2) is a promising area for molecular targeting in HCC therapy.
  • Further clinical investigations are necessary to validate the efficacy and application of targeting OTUB1 and OTUB2 in HCC treatment.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.7K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K